Guangzhou Red Pine Medical Instrument Co., Ltd., a leading company in the disposable endoscope sector, has reportedly secured “hundreds of millions” of renminbi in a Series D financing round. The round was led by CICC Capital, with significant contributions from Guangzhou Industrial Investment and Capital, Oriza Seed, and other investors. The funds raised will be directed towards product iteration and the strategic development of the company’s overseas business.- Flcube.com
Recent news:
-
Shanghai Designates Backup Suppliers and Specialized Drug Formulations in GY-YD2024-2 Procurement -
Abbott Laboratories' Volt PFA System Receives EU CE Mark for Atrial Fibrillation Treatment -
Alcon Laboratories Acquires Majority Stake in Aurion Biotech to Advance Eye Disease Cell Therapy -
Genmab's Tivdak Approved in Japan for Advanced Cervical Cancer Treatment -
CStone Pharmaceuticals Reports 2024 Results with License Fee Growth Offsetting Drug Sales Decline
